FDA Drug Application (021301) for LEVOXYL by KING PHARMS R AND D

Back to FDA Applications sponsored by KING PHARMS R AND D

Application Number021301
Product Number001
FormTABLET;ORAL
Dosage0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1,AB3 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLEVOXYL
Active IngredientLEVOTHYROXINE SODIUM

Active IngredientCount
List of drugs with Active Ingredient LEVOTHYROXINE SODIUM9


Back to FDA Applications sponsored by KING PHARMS R AND D